Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Bullish option flow detected in CVS Health (CVS) with 33,211 calls trading, 1.7x expected, and implied vol increasing over 7 points to 47.44%.

The pharmaceutical landscape enters 2025 with a mix of challenges and opportunities, with the potential to shape the future ...

CVS faces strong competition from Amazon, Walmart, and Costco, impacting market share. Read why I maintain a Hold rating for ...

A state law that went into effect this week aims to regulate the role of third-party pharmacy benefit managers, who many say ...

CVS Caremark will add Zydus' ZituvioTM and combination products to its template formulary starting January 1, 2025 ...

Zydus Lifesciences reacted sharply to the development in Tuesday's trade with the counter rising 5.23 percent to an intraday high of Rs 1,011.75 per share on the NSE.

CVS' Aetna sues drug manufacturers for price-fixing and market allocation scheme. The subsidiary seeks damages and ...

Three laws regarding the healthcare industry will see an impact on both staff and patients in Washington and Idaho on January 1, 2025.

Businesspeople, healthcare workers, a teacher and a former England football manager are among those from the Harrogate District to receive awards in The King’s New Year Honours List 2025.

Out of all of the special options we uncovered, 6 are puts, for a total amount of $241,558, and 4 are calls, for a total ...

Investors in CVS Health Corporation (Symbol: CVS) saw new options become available today, for the February 2025 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down ...